ViiV Healthcare Advances Twice-Yearly HIV Treatmen...
Category : Clinical Trial Update 3 March 2026The future of HIV treatment may require just two doses per year. At CROI 2026 in Denver, ViiV Health...
Clinical Trial Update
XellSmart Pharmaceutical Co., Ltd. Secures Fourth...
Category : Clinical Trial Update 3 March 2026XellSmart is expanding deeper into neurodegenerative disease. The company has secured its fourth joi...
Lilly’s Orforglipron Beats Oral Semaglutide in Lan...
Category : Clinical Trial Update 28 February 2026Eli Lilly and Company has released detailed results from ACHIEVE-3, a pivotal Phase 3 study in type...
Vanda’s Imsidolimab Moves Closer to Approval for R...
Category : Clinical Trial Update 28 February 2026Vanda Pharmaceuticals Inc. has reached a key regulatory milestone. The US Food and Drug Administrati...
GSK Files NDA for Bepirovirsen in Japan for Chroni...
Category : Clinical Trial Update 27 February 2026GSK plc has taken a key regulatory step in Japan. The company announced that Japan’s Ministry...
Latest Newsletter Post
-
Insilico Medicine’s AI-Discovered C..
9 March 2026
-
Aisa Pharma Inc. Reports Encouragin..
9 March 2026
-
Roche Reports Positive Phase II Res..
9 March 2026
-
Study Highlights Pharmacokinetic Ad..
8 March 2026
-
FDA Grants Breakthrough Therapy Des..
8 March 2026
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com